Investors Overview

Investors Overview

An emerging leader in the immunotherapy space, we are advancing a pre-clinical pipeline of therapeutic candidates intended to elicit broad and durable anti-tumor and anti-viral responses and cure disease.

Stock Quote

Current value on NASDAQ*

*Stock Price may not reflect real time results

SEC Filings

U.S. Securities and Exchange Commission filings
View SEC Filings

Investor Contact

Indaptus Management

View Management Team

Indaptus Board of Directors

View Board of Directors

Press Releases

View Press Releases

Annual Meeting

View Meetings

Corporate Governance

View Documents and Charters

Events and Presentations

Sept 12, 2022

24th Annual H.C. Wainwright Global Investment Conference | Webcast Link

June 16, 2022

JMP Securities Life Sciences Conference | Webcast Link

June 8 – 10, 2022

Jefferies Healthcare Conference | Webcast Link

May 23 – 26, 2022

H.C. Wainwright Global Investment Conference | Webcast Link

March 28 – 30, 2022

2022 Virtual Growth Conference | Webcast Link

March 14 – 15, 2022

34th Annual ROTH Conference | Webcast Link

January 10, 2022 at 7AM ET

H.C. Wainwright BioConnect 2022 Virtual Conference | Webcast Link


September 2022

Investor Presentation